Electronic physician notification to facilitate the recognition and management of severe aortic stenosis: Rationale, design, and methods of the randomized controlled DETECT AS trial

被引:0
|
作者
Abou-Karam, Roukoz [1 ,2 ]
Tanguturi, Varsha [3 ]
Cheng, Fangzhou [1 ,2 ]
Elmariah, Sammy [4 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, Boston, MA USA
[2] Broad Inst MIT & Harvard, Cardiovasc Dis Ini tiat, Cambridge, MA USA
[3] Massachusetts Gen Hosp, Dept Med, Cardiol Div, Boston, MA USA
[4] Univ Calif San Francisco, Dept Med, Div Cardiovasc Med, 505 Parnassus Ave,room L-523, San Francisco, CA 94143 USA
关键词
VALVE-REPLACEMENT; SYMPTOMATIC PATIENTS; NATURAL-HISTORY; OUTCOMES; TRANSCATHETER; DISEASE; DISPARITIES; GRADIENT; SURGERY; SOCIETY;
D O I
10.1016/j.ahj.2024.06.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Symptomatic severe aortic stenosis causes substantial morbidity and mortality when left untreated, yet recent data suggest its undertreatment. Objective To evaluate the efficacy of electronic physician notification to facilitate the guideline-directed management of patients with severe aortic stenosis. Hypothesis We hypothesize that patients with severe aortic stenosis who are in the care of physicians who receive the notification are more likely to undergo aortic valve replacement within one year. Methods/Design The Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis (DETECT AS) trial is a randomized controlled trial and quality improvement initiative designed to evaluate the efficacy of electronic provider notification versus usual clinical care in the management of patients with severe aortic stenosis. Providers ordering an echocardiogram with findings potentially indicative of severe aortic stenosis are randomized to receive electronic notification with customized guideline recommendations for the management of severe aortic stenosis or usual care (no notification). Randomization continues until 940 patients are enrolled. Setting Multicentered, academic health system. Outcomes The primary endpoint is the proportion of patients with severe aortic stenosis receiving an aortic valve replacement within one year of the index echocardiogram. Secondary endpoints include mor tality, hear t failure hospitalization, transthoracic echocardiogram utilization, aortic stenosis billing code, and cardiology/Valve Team referral. Conclusion The DETECT AS trial will provide insight into whether electronic notification of providers on the presence of severe aortic stenosis and associated clinical guideline recommendations will facilitate recognition and guideline-directed management of severe aortic stenosis.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 50 条
  • [21] Homeopathy for seasonal allergic rhinitis: rationale, design and methods of the three-armed randomized controlled HOMEOSAR trial
    Siewert, J.
    Teut, M.
    Gaertner, K.
    Binting, S.
    Eberhardt, C.
    Ortiz, M.
    Grabowska, W.
    Reinhold, T.
    Roll, S.
    Stoeckigt, B.
    Willich, S. N.
    Cramer, H.
    Brinkhaus, B.
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2022, 22 (01)
  • [22] A randomized controlled trial of a trauma-informed school prevention program for urban youth: Rationale, design, and methods
    Mendelson, Tamar
    Clary, Laura K.
    Sibinga, Erica
    Tandon, Darius
    Musci, Rashelle
    Mmari, Kristin
    Salkever, David
    Stuart, Elizabeth A.
    Ialongo, Nick
    CONTEMPORARY CLINICAL TRIALS, 2020, 90
  • [23] Rationale, design, and methods for a pivotal randomized clinical trial of continuous aortic flow augmentation in patients with exacerbation of heart failure: The MOMENTUM trial
    Greenberg, Barry
    Czerska, Barbara
    Abraham, William T.
    Neaton, James D.
    Delgado, Reynolds M.
    Mather, Paul
    Bourge, Robert
    Parker, Irene C.
    Konstam, Marvin A.
    JOURNAL OF CARDIAC FAILURE, 2007, 13 (09) : 715 - 721
  • [24] PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial
    Hu, Xinzhi
    Zhang, Zongmuyu
    Liu, Caiyan
    Li, Mingli
    Liu, Yiyang
    Cheng, Anqi
    Yu, Qiuyu
    Guo, Haoyao
    Zou, Yinxi
    Zhou, Li
    Wang, Hebo
    Song, Bo
    You, Yong
    Xia, Jian
    Zhang, Jingfen
    Ai, Zhibing
    Sun, Qinjian
    Han, Ju
    Liu, Jing
    Lu, Baoquan
    Deng, Qiwen
    Li, Guanzeng
    Wang, Peng-fei
    Li, Xiangqing
    An, Yi
    Wu, Bo
    Yan, Zhongrui
    Wang, Yining
    Xu, Wei-Hai
    INTERNATIONAL JOURNAL OF STROKE, 2024, 19 (09) : 1071 - 1076
  • [25] Design and rationale of the medical students learning weight management counseling skills (MSWeight) group randomized controlled trial
    Ockene, Judith K.
    Ashe, Karen M.
    Hayes, Rashelle B.
    Churchill, Linda C.
    Crawford, Sybil L.
    Geller, Alan C.
    Jolicoeur, Denise
    Olendzki, Barbara C.
    Basco, Maria Theresa
    Pendharkar, Jyothi A.
    Ferguson, Kristi J.
    Guck, Thomas P.
    Margo, Katherine L.
    Okuliar, Catherine A.
    Shaw, Monica A.
    Soleymani, Taraneh
    Stadler, Diane D.
    Warrier, Sarita S.
    Pbert, Lori
    CONTEMPORARY CLINICAL TRIALS, 2018, 64 : 58 - 66
  • [26] Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial
    Johnson, Heather M.
    Sullivan-Vedder, Lisa
    Kim, KyungMann
    McBride, Patrick E.
    Smith, Maureen A.
    LaMantia, Jamie N.
    Fink, Jennifer T.
    Sinaise, Megan R. Knutson
    Zeller, Laura M.
    Lauver, Diane R.
    CONTEMPORARY CLINICAL TRIALS, 2019, 78 : 88 - 100
  • [27] Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial
    Kawashima, Hideyuki
    Soliman, Osama
    Wang, Rutao
    Ono, Masafumi
    Hara, Hironori
    Gao, Chao
    Zeller, Emeline
    Thakkar, Ashokkumar
    Tamburino, Corrado
    Bedogni, Francesco
    Neumann, Franz-Josef
    Thiele, Holger
    Abdel-Wahab, Mohamed
    Morice, Marie-Claude
    Webster, Mark
    Rosseel, Liesbeth
    Mylotte, Darren
    Onuma, Yoshinobu
    Wijns, William
    Baumbach, Andreas
    Serruys, Patrick W.
    AMERICAN HEART JOURNAL, 2021, 232 : 23 - 38
  • [28] Active video games as a tool to prevent excessive weight gain in adolescents: rationale, design and methods of a randomized controlled trial
    Simons, Monique
    Chinapaw, Mai J. M.
    van de Bovenkamp, Maaike
    de Boer, Michiel R.
    Seidell, Jacob C.
    Brug, Johannes
    de Vet, Emely
    BMC PUBLIC HEALTH, 2014, 14
  • [29] Rationale, Design, and Methods for the Sedentary Behavior Reduction in Pregnancy Intervention (SPRING): Protocol for a Pilot and Feasibility Randomized Controlled Trial
    Gibbs, Bethany Barone
    Kozai, Andrea C.
    McAdoo, Shannon N.
    Bastyr, Meghan C.
    Davis, Kelliann
    Hauspurg, Alisse
    Catov, Janet M.
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [30] Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale
    Galindo-Mendez, B.
    Trevino, J. A.
    McGlinchey, R.
    Fortier, C.
    Lioutas, V
    Novak, P.
    Mantzoros, C. S.
    Ngo, L.
    Novak, V
    CONTEMPORARY CLINICAL TRIALS, 2020, 89